全文获取类型
收费全文 | 1899篇 |
免费 | 98篇 |
国内免费 | 2篇 |
专业分类
耳鼻咽喉 | 27篇 |
儿科学 | 153篇 |
妇产科学 | 44篇 |
基础医学 | 203篇 |
口腔科学 | 23篇 |
临床医学 | 149篇 |
内科学 | 261篇 |
皮肤病学 | 52篇 |
神经病学 | 123篇 |
特种医学 | 43篇 |
外科学 | 224篇 |
综合类 | 85篇 |
预防医学 | 93篇 |
眼科学 | 23篇 |
药学 | 244篇 |
中国医学 | 14篇 |
肿瘤学 | 238篇 |
出版年
2022年 | 11篇 |
2021年 | 45篇 |
2020年 | 24篇 |
2019年 | 47篇 |
2018年 | 44篇 |
2017年 | 30篇 |
2016年 | 59篇 |
2015年 | 59篇 |
2014年 | 77篇 |
2013年 | 77篇 |
2012年 | 100篇 |
2011年 | 125篇 |
2010年 | 65篇 |
2009年 | 46篇 |
2008年 | 78篇 |
2007年 | 72篇 |
2006年 | 78篇 |
2005年 | 64篇 |
2004年 | 74篇 |
2003年 | 58篇 |
2002年 | 55篇 |
2001年 | 40篇 |
2000年 | 47篇 |
1999年 | 46篇 |
1998年 | 16篇 |
1996年 | 13篇 |
1995年 | 10篇 |
1994年 | 15篇 |
1992年 | 29篇 |
1991年 | 18篇 |
1990年 | 31篇 |
1989年 | 30篇 |
1988年 | 35篇 |
1987年 | 30篇 |
1986年 | 32篇 |
1985年 | 30篇 |
1984年 | 25篇 |
1983年 | 26篇 |
1979年 | 24篇 |
1977年 | 13篇 |
1976年 | 9篇 |
1974年 | 22篇 |
1973年 | 9篇 |
1972年 | 16篇 |
1971年 | 17篇 |
1970年 | 12篇 |
1969年 | 11篇 |
1968年 | 16篇 |
1967年 | 15篇 |
1966年 | 8篇 |
排序方式: 共有1999条查询结果,搜索用时 250 毫秒
1.
Awais Nasir Deepsha Agrawal Jayashree Pathak Iakovos Theodoulou 《The British journal of radiology》2021,94(1117)
Coronavirus disease 19 (Covid-19) poses a huge threat to health systems and economies worldwide. So far, there has been no proven effective treatment for SARS-CoV-2 infection. Various potential therapies, viz., immunomodulatory agents, antiviral therapy, and plasma transfusion, are undergoing clinical trials. An intensive search of the medical corpora revealed that low dose X-ray radiation therapy has been used in the past to treat interstitial pneumonia. In this article we explore a historical background of low-dose X-rays for the treatment of pneumonia and how it could be a promising therapy in treating patients with COVID-19. 相似文献
2.
3.
Meenakshi Pathak Allan G.A. Coombes BoMi Ryu Peter J. Cabot Mark S. Turner Cheryn Palmer Dongjie Wang Kathryn J. Steadman 《Journal of pharmaceutical sciences》2018,107(3):863-869
Poly(?-caprolactone) (PCL) intravaginal matrices were produced for local delivery of a combination of antibacterials, by rapidly cooling a mixture of drug powders dispersed in PCL solution. Matrices loaded with different combinations of metronidazole (10%, 15%, and 20% w/w) and doxycycline (10% w/w) were evaluated in vitro for release behavior and antibacterial activity. Rapid “burst release” of 8%-15% of the doxycycline content and 31%-37% of the metronidazole content occurred within 24 h when matrices were immersed in simulated vaginal fluid at 37°C. The remaining drug was extracted gradually over 14 days to a maximum of 65%-73% for doxycycline and 62%-71% for metronidazole. High levels of antibacterial activity up to 89%-91% against Gardnerella vaginalis and 84%-92% against Neisseria gonorrhoeae were recorded in vitro for release media collected on day 14, compared to “nonformulated” metronidazole and doxycycline solutions. Based on the in vitro data, the minimum levels of doxycycline and metronidazole released from PCL matrices in the form of intravaginal rings into vaginal fluid in vivo were predicted to exceed the minimum inhibitory concentrations for N. gonorrhea (reported range 0.5-4.0 μg/mL) and G. vaginalis (reported range 2-12.8 μg/mL) respectively, which are 2 of the major causative agents for pelvic inflammatory disease. 相似文献
4.
Synthesis,molecular docking,and pharmacological evaluation of N‐(2‐(3,5‐dimethoxyphenyl)benzoxazole‐5‐yl)benzamide derivatives as selective COX‐2 inhibitors and anti‐inflammatory agents 下载免费PDF全文
5.
Rajput JS Jain RL Pathak A 《Journal of the Indian Society of Pedodontics and Preventive Dentistry》2004,22(1):1-7
An in vitro dye leakage study was carried out to compare the apical microleakage of vitapex (calcium hydroxide based paste) when used with single gutta percha cone with that of dentalis KEZ (calcium hydroxide and zincoxide eugenol based sealer) and zincoxide-eugenol sealer when used with laterally condensed gutta percha obturation technique. One hundred single rooted human anterior teeth were instrumented and randomly divided into three experimental groups of 30 teeth each and two control groups of 5 teeth each. Teeth in the first group were obturated using a single master gutta percha cone and vitapex as root canal sealer and those of second group were obturated with laterally condensed gutta percha using dentalis KEZ as sealer. Third experimental group was filled with laterally condensed gutta-percha using zinc-oxide eugenol as sealer. Teeth were then suspended in 2% methylene blue. After this, teeth were demineralized dehydrated and cleared. Linear dye penetration was determined under stereomicroscope (x10) with calibrated eye piece. Results of this study showed that calcium hydroxide based endodontic material leaked comparatively less as compared to zinc oxide Eugenol sealer. Vitapex with single gutta-percha cone provided an adequate apical Seal against dye penetration. 相似文献
6.
Aparna M. Prabhu Sheel Pathak Divya Khurana Agustin Legido Karen Carvalho Ignacio Valencia 《Epileptic Disord》2014,16(1):45-49
Myoclonus is a brief, rapid, involuntary muscle jerk originating in the central nervous system that can be physiological or a symptom of disease. We report a group of five children with excessive myoclonic jerks, only during sleep, and abnormal EEG during the events. Although only one third of the events had EEG epileptiform correlate, the presence of myoclonus without epileptiform EEG correlate has been described in patients with benign myoclonic epilepsy of infancy. We hypothesize that these findings may represent a variant of benign myoclonic epilepsy of infancy. 相似文献
7.
8.
9.
Sara E. Murray Priya R. Pathak Sarah C. Schaefer Herbert Chen Rebecca S. Sippel 《World journal of surgery》2014,38(3):542-548
Background
The aim of the present study was to investigate the incidence of sleep disturbance and insomnia in patients with primary hyperparathyroidism (PHPT), and to evaluate the effect of parathyroidectomy.Methods
A questionnaire was prospectively administered to adult patients with PHPT who underwent curative parathyroidectomy over an 11-month period. The questionnaire, administered preoperatively and 6 months postoperatively, included the Insomnia Severity Index (ISI) and eight additional questions regarding sleep pattern. Total ISI scores range from 0 to 28, with >7 signifying sleep difficulties and scores >14 indicating clinical insomnia.Results
Of 197 eligible patients undergoing parathyroidectomy for PHPT, 115 (58.3 %) completed the preoperative and postoperative questionnaires. The mean age was 60.0 ± 1.2 years and 80.0 % were women. Preoperatively, 72 patients (62.6 %) had sleep difficulties, and 29 patients (25.2 %) met the criteria for clinical insomnia. Clinicopathologic variables were not predictive of clinical insomnia. There was a significant reduction in mean ISI score after parathyroidectomy (10.3 ± 0.6 vs 6.2 ± 0.5, p < 0.0001). Postoperatively, 79 patients (68.7 %) had an improved ISI score. Of the 29 patients with preoperative clinical insomnia, 21 (72.4 %) had resolution after parathyroidectomy. Preoperative insomnia patients had an increase in total hours slept after parathyroidectomy (5.4 ± 0.3 vs 6.1 ± 0.3 h, p = 0.02), whereas both insomnia patients and non-insomnia patients had a decrease in the number of awakenings (3.7 ± 0.4 vs 1.9 ± 0.2 times, p = 0.0001).Conclusions
Sleep disturbances and insomnia are common in patients with PHPT, and the majority of patients will improve after curative parathyroidectomy. 相似文献10.
Pathak MK Dhawan D Lindner DJ Borden EC Farver C Yi T 《Molecular cancer therapeutics》2002,1(14):1255-1264
The PRL family oncogenic phosphatases are attractive targets for developing inhibitors as anticancer therapeutics given their potentially pathogenic role in human malignancies. Herein we demonstrate that pentamidine, an anti-protozoa drug with an unknown mechanism of action, is an inhibitor of PRLs with anticancer potential. Pentamidine at its therapeutic doses inhibited recombinant PRL phosphatases in vitro and inactivated ectopically expressed PRLs in NIH3T3 transfectants with an effective duration more than 24 h after a pulse cell treatment. The drug had in vitro growth-inhibitory activity against human cancer cell lines that express the endogenous PRLs. Pentamidine at a tolerable dose markedly inhibited the growth of WM9 human melanoma tumors in nude mice coincident with the induction of tumor cell necrosis and is capable of inactivating ectopically expressed PRL-2 in the cancer cells. These observations suggest the potential of pentamidine in anticancer therapies and may provide a basis for developing novel PTPase-targeted therapeutics. 相似文献